Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
批准号:
10341226
负责人:
John Charles O'Donnell
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-02-01 至 2026-01-31
关键词:
AccelerationAcheAcuteAnimal ModelAnimalsAnisotropyAutopsyBlindedBloodBrainBrain InjuriesBrain MassBrain-Derived Neurotrophic FactorBranched-Chain Amino AcidsCaringChronicClinicalClinical ManagementClinical ResearchCognitionCognitive deficitsComaCommunitiesDataData CollectionDiagnosticDietary SupplementationDiffuseDiffuse Axonal InjuryDiffusion Magnetic Resonance ImagingDoctor of PhilosophyElectrophysiology (science)EnrollmentEnvironmentEtiologyEvaluationExerciseFamily suidaeFatigueFoundationsFrequenciesFutureGaitGeneral PopulationGoalsHeadHistopathologyHumanImmunohistochemistryIndividualInjuryInterventionInvestigationInvestmentsK-Series Research Career ProgramsKnowledgeLifeLongitudinal StudiesMedical centerMentorsMentorshipMissionModelingMonitorNerve DegenerationNervous System TraumaNeurologicOutcomeOutputPathologyPathway interactionsPatientsPennsylvaniaPhasePhiladelphiaPhysical ExercisePlacebosPre-Clinical ModelProtocols documentationRandomizedRecoveryRecovery of FunctionRehabilitation therapyResearchResearch PersonnelResolutionResourcesRodent ModelRotationSample SizeSerumServicesSeveritiesSignal TransductionSleepSleep DeprivationSleep disturbancesSliceStructureSystemTestingTherapeuticTimeTranslationsTraumatic Brain InjuryTraumatic Brain Injury recoveryUnconscious StateUnit of MeasureUniversitiesVeteransactigraphyamino acid therapybrain sizecareerclinically relevantcognitive enhancementcognitive recoverycognitive testingdiet and exercisedietarydriving forceeffective therapyefficacy testingexercise rehabilitationexperienceimprovedin vivointerestlong-term rehabilitationmembermilitary veteranmultimodalityneurobehavioralneuroimagingneurological rehabilitationneuroprotectionnovel therapeuticspatient variabilityporcine modelpre-clinicalprognosticrehabilitation researchrehabilitation strategyresearch and developmentrestorationsevere injurysleep qualitytherapeutic targettherapy developmenttractographytranslational modeltreadmilltreatment group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The motivating force driving me to build an independent research enterprise has been my personal desire to
maximize functional recovery after traumatic brain injury (TBI). Experiences in my life have solidified this
research goal as one of primary purpose, and my career trajectory and accomplishments through adversity
stand as evidence of my devotion to that purpose and ability to acheive it. This mission brought me to the
Philadelphia CMC VA Medical Center (CMC-VAMC), where I have found that my own research goals align
perfectly with those of the Rehabilitation R&D (RR&D) Service and the needs of our Veterans. To make the
greatest impact on TBI rehabilitation, I will utilize a unique large animal model to accurately replicate the
mechanisms and manifestations of human TBI: the swine rotational acceleration system applied to great effect
by my mentor, D. Kacy Cullen, PhD, and other researchers in his Center for Neurotrauma, Neurodegeneration,
and Restoration at the CMC-VAMC and University of Pennsylvania. In addition to diffuse axonal injury, this
model results in damage to the ascending reticular activating system (ARAS) as observed in moderate TBI in
humans, leading to temporary loss of consciousness and lasting effects on sleep, fatigue, and cognition that are
major factors during recovery from TBI. Due to their small brain size, our commonly used rodent models
cannot be used to reproduce these aspects of the human injury or their manifestations, as the damage is a
product of rotational acceleration and brain mass. In this project I propose to build on the swine model,
extending beyond the acute injury period following moderate TBI to establish the first translational model of
moderate TBI Rehabilitation and Recovery at long-term time points most relevant for our Veteran population.
Such a high-fidelity preclinical model will provide the rigor and control necessary to directly test the efficacy of
individual ingredients of rehabilitation therapies (e.g. diet, exercise) and conduct detailed mechanistic
investigations to inform adjustments to existing therapies and development of new therapies that improve
efficacy. I will christen this vessel of bidirectional translation with a blinded, randomized investigation of the
efficacy and mechanisms of action of dietary branched-chain amino acid (BCAA) therapy for enhancing
cognitive recovery over a three-month study period (including investigation of Veteran-relevant delayed therapy
administration). Our studies will benefit greatly from clinically-relevant advanced neuroimaging, a gamut of
clinically-inspired neurobehavioral and neurological testing, extensive histopathological and
immunohistochemical analyses, and high-resolution post-mortem diffusion tensor imaging with anisotropy,
diffusivity, and tractography to quantify changes in brain connectivity that are a hallmark of human TBI. I will
also utilize this model to test the mechanisms and efficacy of regular exercise rehabilitation or exercise plus
BCAAs for improving recovery trajectory over a six-month period (also with Veteran-relevant delayed
treatment). Previous studies suggest that exercise and BCAA therapies share common mechanisms of action
and effects, and therefore I will effectively be testing the overarching hypothesis that enhancing neurotrophic
signaling and improving sleep quality after injury can improve cognitive recovery and reduce ARAS pathology
following moderate TBI. Beyond the advancements that this project will provide for our mission to maximize
functional recovery from brain injury in our Veterans, I will be gathering invaluable knowledge and expertise
from a dedicated, world-class mentorship team and carving a niche for my future career as an independent VA
investigator. Due to the swine model and the community of researchers gathered around it, the CMC-VAMC
and University of Pennsylvania are at the epicenter of translational TBI research. The greatest environment in
the world to achieve my research goals in TBI rehabilitation is within this community, and I intend to become an
integral member throughout my career. I will achieve independence through this Career Development Award
and provide considerable return on investment through a highly productive VA research career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
-
批准号:10557786
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John Charles O'Donnell
-
依托单位:
Translational Modeling of Brain Injury Rehabilitation to Maximize Recovery.
-
批准号:10183457
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:John Charles O'Donnell
-
依托单位:
Modeling Disorders of Consciousness
-
批准号:9533191
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2017
-
负责人:John Charles O'Donnell
-
依托单位:
Mitochondrial dynamics in astrocytic processes after transient ischemia
-
批准号:8921078
-
项目类别:
-
资助金额:$3.73万
-
财政年份:2014
-
负责人:John Charles O'Donnell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
转录因子BMAL1调控AChE在昼夜节律紊乱致认知损害中的作用及分子机制
-
批准号:2024Y9230
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:姜雨
-
依托单位:
基于无机基质固定碳点光学探针研究有机磷农药暴露AChE响应的活体测量
-
批准号:
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2024
-
负责人:冯锋
-
依托单位:
基于AChE/NLRP3 靶点研究垂穗石松中抗AD新型黄酮苷
吐星酸酯类成分的发现及作用机制研究
-
批准号:2024JJ8138
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:谭蕾红
-
依托单位:
基于GSK-3β/AChE双重抑制的抗AD杂交分子的设计、合成及作用机制研究
-
批准号:22367005
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:董永喜
-
依托单位:
基于可逆界面传质调控机制的AChE固定化荧光传感器及有机磷农药高灵敏抗干扰速测
-
批准号:32372427
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:冷远逵
-
依托单位:
利用微流体技术合成富缺陷MOFs材料定向捕获AChE酶构筑高性能传感界面
-
批准号:32302225
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋丹丹
-
依托单位:
抗基质干扰导向的AChE仿生荧光探针的设计合成及农药残留速测应用
-
批准号:--
-
项目类别:面上项目
-
资助金额:53万元
-
批准年份:2022
-
负责人:郝振霞
-
依托单位:
基于高分辨活性轮廓分析的中药AChE/GSK3β双靶点抑制剂高内涵筛选研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:翟蔓华芸
-
依托单位:
新型AChE/NLRP3双靶点抑制剂—藤石松中抗AD新颖黄酮苷吐星酸酯类成分的发现及作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:刘阳
-
依托单位:
基于AchE靶点的苗药三两银抗阿尔兹海默症甾体生物碱类化合物发现与作用机制研究
-
批准号:82260833
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:於祥
-
依托单位: